Search Within

Jennifer Lynn Sauter

Formats
  1. Journal Article (61)
  2. Meeting Abstract (60)
  3. Review (4)
  4. Guidelines (3)
  5. Correspondence (2)
Groups
  1. Department of Pathology and Laboratory Medicine (130)
  2. Department of Medicine (87)
  3. Solid Tumor Oncology Division (84)
  4. Thoracic Oncology (84)
  5. GSK Faculty (67)
  6. Surgery (64)

More Groups

People
  1. William Travis (75)
  2. Natasha Rekhtman (57)
  3. Marc Ladanyi (44)
  4. Jason Chang (43)
  5. Marjorie Zauderer (40)
  6. Prasad Adusumilli (36)

More People

Years
  1. 2025 (11)
  2. 2024 (17)
  3. 2023 (7)
  4. 2022 (14)
  5. 2021 (18)
  6. 2020 (24)

More Years

Publications
  1. Journal of Thoracic Oncology (26)
  2. Modern Pathology (23)
  3. Laboratory Investigation (22)
  4. Journal of Clinical Oncology (14)
  5. Clinical Cancer Research (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (30)
  2. Nature Research (24)
  3. Nature Publishing Group (22)
  4. American Society of Clinical Oncology (14)
  5. American Association for Cancer Research (12)
  6. Oxford University Press (5)

More Publishers

Results (130)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma
    Journal Article

    Skoulidis, F.; Goldberg, M. E.; Greenawalt, D. M.; Hellmann, M. D.; Awad, M. M.; Gainor, J. F.; Schrock, A. B.; Hartmaier, R. J.; Trabucco, S. E.; Gay, L.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
    Journal Article

    Hellmann, M. D.; Nathanson, T.; Rizvi, H.; Creelan, B. C.; Sanchez-Vega, F.; Ahuja, A.; Ni, A.; Novik, J. B.; Mangarin, L. M. B.; Abu-Akeel, M.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Prominent expression of the negative immune checkpoint regulator VISTA in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Muller, S.; Zauderer, M.; Desmeules, P.; Jungbluth, A.; Fayad, M.; Frosina, D.; Ni, A.; Ladanyi, M.; Sauter, J. L.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Shahi, M.; Eguchi, T.; Zauderer, M.; Travis, W.; Jungbluth, A.; Frosina, D.; Fayad, M.; Asher, M.; Adusumilli, P. S.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • SMARCA4 (BRG1) deficiency in lung carcinomas correlates with poor differentiation and aggressive clinical behavior
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Beras, A.; Namakydoust, A.; Rudin, C.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma: Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Jungbluth, A.; Beras, A.; Namakydoust, A.; Rudin, C.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Histologic features predictive of response to PD-1 blockade in patients with non small cell lung carcinoma (NSCLC)
    Meeting Abstract

    Alex, D.; Travis, W.; Rekhtman, N.; Buonocore, D.; Ni, A.; Rizvi, H.; Hellmann, M.; Sauter, J. L.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: A multi-institutional study
    Journal Article

    Rosen, L. E.; Karrison, T.; Ananthanarayanan, V.; Gallan, A. J.; Adusumilli, P. S.; Alchami, F. S.; Attanoos, R.; Brcic, L.; Butnor, K. J.; Galateau-SalleĢ, F.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: Evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center
    Journal Article

    Marchevsky, A. M.; LeStang, N.; Hiroshima, K.; Pelosi, G.; Attanoos, R.; Churg, A.; Chirieac, L.; Dacic, S.; Husain, A.; Khoor, A.; more...
    Human Pathology (2017)

    Fulltext@MSK | Save